Velan Capital Investment Management »

Profound Med Corp shares owned by Velan Capital Investment Management

Quarter-by-quarter ownership of Profound Med Corp (PROF) shares owned by Velan Capital Investment Management from 13F filings

Historical chart of Velan Capital Investment Management investment in Profound Med Corp

Tip: Access up to 7 years of quarterly data

All positions including Profound Med Corp held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Profound Med Corp by Velan Capital Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 286k 7.87

More positions owned by Velan Capital Investment Management

Praxis Precision Medicines I Com New (PRAX)
Cidara Therapeutics Com New (CDTX)
Protara Therapeutics Com Stk (TARA)
Heron Therapeutics (HRTX)
Maplight Therapeutics (MPLT)
Abivax Sa Sponsored Ads (ABVX)
Evommune Com Shs (EVMN)
Mineralys Therapeutics (MLYS)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Jasper Therapeutics Com New (JSPR)
Avalo Therapeutics Com New (AVTX)
Esperion Therapeutics (ESPR)
Verrica Pharmaceuticals Com Shs (VRCA)
Inspiremd (NSPR)
Rapt Therapeutics Com New (RAPT)

View all positions for Velan Capital Investment Management

Top funds holding Profound Med Corp

Gagnon Securities
Fil
Rosalind Advisors
Royce & Associates
Timelo Investment Management
Letko, Brosseau & Associates
Gagnon Advisors
Alyeska Investment Group
MMCAP International Inc. SPC
Royal Bank of Canada
Ring Mountain Capital
Ardsley Advisory Partners
First Eagle Investment Management
Essex Investment Management
DAFNA Capital Management

View all funds holding Profound Med Corp